Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1025.0000 (0%) ($0.0000 - $0.0000) on Wed. Aug. 29, 2007. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 13.41% (three month average) | | RSI | 0 | | Latest Price | $1025.0000(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
EWJ(0%) FXI(-0%) IWM(0%) OIH(0%) PEJ(-0%) | | Factors Impacting CAPR price | CAPR will decline at least -6.705% in a week (0% probabilities).
GLD(-4%) TLT(-3%) TIP(-3%) XLU(-2%) EWP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -6.705% (StdDev 13.41%) | | Hourly BBV | 0 () | | Intraday Trend | INF% | | | | | |
|
| 5 Day Moving Average | $1025(0%) | | 10 Day Moving Average | $1025(0%) | | 20 Day Moving Average | $1025(0%) | | To recent high | 0% | | To recent low | 78.3% | | Market Cap | $20.19b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |